报告题目：Transmembrane targeting peptides as novel anti-cancer agents
报告时间：2015年9月24日 上午10:00
报告地点：神经科学研究所会议室
报告人简介：
BAGNARD教授，现任职于法国Strasbourg大学，助理教授，分子与细胞神经生物学项目组主席。1996年获得里昂第一大学硕士学位，同年进入University Claude Bernard Lyon 1 France and Max Planck Institüt Frankfurt, Germany攻读博士学位，2000年于Neurological Hospital, Lyon完成博士后训练，2004年至今就职于Strasbourg大学。
BAGNARD教授，至今发表了55篇研究论文，综述，评论文章或专著，担任国际优秀期刊《Cell Adhesion and Migration》的总编辑及《Current Pharmaceutical Design》客座编辑，同时还是Mimesis Pharma公司创始人之一。
EDUCATION AND TRAINING
1995-1996: Master of Neurosciences (University 5th year)
University Claude Bernard, Lyon I, France.
1996-1999: PhD in Neurosciences under the supervision of Pr. Dr. J. Bolz (INSERM U371 “Brain and Vision” University Claude Bernard Lyon 1 France and Max Planck Institüt Frankfurt, Germany (Dir: AW Püschel)
1999-2000 Postdoc position - Neurobiotec (Neurological Hospital, Lyon)
2004- Research Habilitation. INSERM U575 (Physiopathology of the nervous system). University of Strasbourg, France
MAJOR ACHIEVEMENTS
Assistant Professor; chair of the Molecular and Cellular Neurobiology program of the University of Strasbourg
- Nominated member of the National Council of Universities (Neurosciences section, 2003-2011)
- National and International prizes: best scientific contribution at the 2003 Roche meeting for leading Bioscientists of the next Decade, 2008 Prize of the French foundation for Medical Research (FRM)- Rotary International, 2011 International prize for biomedical innovation “Universal Biotech”)
- Guest editor for Current Pharmaceutical Design (2005-2007)
- Founder and Editor in chief of Cell Adhesion and Migration (ISI, Scopus, Pub Med indexed international peer reviewed journal; 2013 IF: 3.4)
- Authors and co-authors of 55 research papers, reviews, editorials or books (ISI source)
- Co-founder of the startup company Mimesis Pharma (2014)
(学部办公室)
